Gene · 1439
NIH grants1,415
NIH grants whose papers are about the gene, through NIH's grant-paper links.
141 to 160 of 1,415
Download this page as JSON| Grant | Title | CSF2RB papers | Newest fiscal year |
|---|---|---|---|
| R01HL118979 | Enhancing Treg Therapeutic Efficacy in GVHD | 1 | 2025 |
| R01HL125886 | Antidote for inhaled CO poisoning based on mutationally engineered neuroglobin | 1 | 2025 |
| R01HL128297 | Pulmonary arteriole occlusion by platelet-neutrophil micro-emboli in Acute Chest Syndrome | 1 | 2025 |
| R01HL156144 | The Biological Consequences of Age-related Clonal Hematopoiesis | 1 | 2025 |
| R01HL162842 | Investigation of the Cellular and Molecular Mechanisms of Thrombocyte Integrin Signaling | 1 | 2025 |
| R01MH113930 | Childhood adversity, DNA methylation, and psychopathology symptoms: A longitudinal study of sensitive periods and chrono-epigenetics | 1 | 2025 |
| R01NS070711 | Nociceptive Mechanisms Underlying Sickle Cell Pain | 1 | 2025 |
| R01NS073671 | Statistical Methods for Integrating Mixed-type Biomarkers and Phenotypes in Neurodegenerative Disease Modeling | 1 | 2025 |
| R25CA181003 | Summer Research Experiences in Quantitative Cancer Sciences and Emerging Technologies | 1 | 2025 |
| R25DK096999 | Undergraduate Discovery Science Experience in Renal Biology and Disease | 1 | 2025 |
| R35CA210807 | Defining Drivers of HPV-associated Carcinogenesis | 1 | 2025 |
| R35GM118048 | Signal-Induced Regulation of Alternative RNA Processing | 1 | 2025 |
| R35GM122564 | Adeno-Associated Virus Gene Therapy Vectors: Molecular Interactions on Cell Entry | 1 | 2025 |
| R35GM130361 | Regulation of mRNA Fate | 1 | 2025 |
| R35GM133747 | Function and fitness consequences of human genetic variation | 1 | 2025 |
| R35GM133754 | Exploring Electronic Polarization in Biomolecular Folding and Interactions | 1 | 2025 |
| R35HL145000 | Engineering biophysical microtechnologies for hematologic applications in health and disease | 1 | 2025 |
| R35NS111644 | The Role of B cells in the Origin and Progression of Multiple Sclerosis | 1 | 2025 |
| R37AI034495 | In Vivo Prevention of Murine GVHD | 1 | 2025 |
| R37AI049653 | Differentiation and Function of Monocytes and Macrophages | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1439/grants?page=8